Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05890404 · ClinicalTrials.gov registry record · NA
SGM Evidenced-Based Mental Healthcare Implementation
A NA study of LGBTQ and CBT, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,410
- Enrollment target
- 1
- Study location
NCT05890404: Recruiting NA study of LGBTQ and CBT, sponsored by Yale University.
NCT05890404 is a NA study of LGBTQ and CBT that is actively recruiting participants, run by Yale University. The registered enrollment target is 1,410 participants, above the 110-participant average among 3 other LGBTQ trials with a reported enrollment target (1182% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05890404, a NA study of LGBTQ and CBT, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,410 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the proposed study is to identify effective strategies for implementing lesbian, gay, bisexual, transgender, and queer (LGBTQ)- affirmative Cognitive-Behavioral Therapy (CBT) at LGBTQ community centers across the United States.
Primary Outcome
Provider implementation fidelity of LGBTQ-Affirmative Therapy will serve as the primary implementation outcome and will be measured using a simulated practice assessment. Providers will watch two brief (three-minute) video clips of an SGM actor roleplaying a presenting concern and briefly describe in writing the clinical approaches they would use to address the concern. Research assistants will code the videos for important themes using a a scale created by expert LGBTQ-affirmative trainers for
Interventions
- BEHAVIORAL LGBTQ-Affirmative CBT Training: Materials Only
- BEHAVIORAL LGBTQ-Affirmative CBT Training: Direct Training
- BEHAVIORAL LGBTQ-Affirmative CBT Training: Local Supervision
Study Locations (1)
New York
- Yale LGBTQ Mental Health Initiative with the Yale School of Public Office - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,410 participants |
| Start Date | 2024-02-08 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT05890404 shows while recruiting
NCT05890404 is an interventional study that assigns participants to a tested intervention. Its 1,410 participants enrollment target places it among the larger protocols in the corpus, above the 110-participant average among 3 other LGBTQ trials with a reported enrollment target (1182% higher).
The record links to 2 conditions, with LGBTQ appearing as the primary indexed condition, and to 3 interventions - of which LGBTQ-Affirmative CBT Training: Materials Only is the first listed.
NCT05890404 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05890404 about?
NCT05890404 is a clinical study titled "SGM Evidenced-Based Mental Healthcare Implementation". The purpose of the proposed study is to identify effective strategies for implementing lesbian, gay, bisexual, transgender, and queer (LGBTQ)- affirmative Cognitive-Behavioral Therapy (CBT) at LGBTQ community centers across the United States.
What is the current status of trial NCT05890404?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,410 participants. The study started on 2024-02-08. Estimated completion is 2028-06-30.
What conditions does trial NCT05890404 study?
This clinical trial studies the following conditions: LGBTQ, CBT.
What interventions are being tested in trial NCT05890404?
The interventions under investigation include: LGBTQ-Affirmative CBT Training: Materials Only (BEHAVIORAL), LGBTQ-Affirmative CBT Training: Direct Training (BEHAVIORAL), LGBTQ-Affirmative CBT Training: Local Supervision (BEHAVIORAL).
Who is sponsoring clinical trial NCT05890404?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05890404 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for LGBTQ
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07042451 · 1,410 participants · NA
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
- NCT07222566 · 1,410 participants · Phase 3
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT05992935 · 1,405 participants · Phase 1
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
- NCT05444582 · 1,404 participants · Phase 4
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI